Abstract
Bullous pemphigoid and pemphigus vulgaris are blistering diseases. Our results show that expression of the integrins α6β4 α3β1is altered in both diseases: α6β4 to a greater extent in the former and α3β1 in the latter disease, respectively. Instead, the extracellular matrix examined resulted normally expressed.
Keywords: bullous pemphigoid, pemphigus vulgaris, integrins
Letters in Drug Design & Discovery
Title: Expression of α6β4 and α3β1 Integrins in Bullous Pemphigoid and Pemphigus Vulgaris
Volume: 2 Issue: 3
Author(s): G. Giannelli, C. Foti, C. Divella, F. Marinosci, D. Bonamonte and S. Antonaci
Affiliation:
Keywords: bullous pemphigoid, pemphigus vulgaris, integrins
Abstract: Bullous pemphigoid and pemphigus vulgaris are blistering diseases. Our results show that expression of the integrins α6β4 α3β1is altered in both diseases: α6β4 to a greater extent in the former and α3β1 in the latter disease, respectively. Instead, the extracellular matrix examined resulted normally expressed.
Export Options
About this article
Cite this article as:
Giannelli G., Foti C., Divella C., Marinosci F., Bonamonte D. and Antonaci S., Expression of α6β4 and α3β1 Integrins in Bullous Pemphigoid and Pemphigus Vulgaris, Letters in Drug Design & Discovery 2005; 2 (3) . https://dx.doi.org/10.2174/1570180053765084
DOI https://dx.doi.org/10.2174/1570180053765084 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel VEGF-independent Strategies Targeting Tumor Vasculature: Clinical Aspects
Current Pharmaceutical Design Current and Future Prospective of a Versatile Moiety: Imidazole
Current Drug Targets Structure-Activity Relationship of Supramolecular Compounds in Drug Delivery
Mini-Reviews in Organic Chemistry Endoscopic Microscopy Using Optical Coherence Tomography
Current Medical Imaging Outcome Measures Following Sonodynamic Photodynamic Therapy – A Case Series
Current Drug Therapy Oncotarget Strategies For Herpes Simplex Virus-1
Current Gene Therapy The Relationship Between Oncogene Expression and Clinical Outcome in Endometrial Carcinoma
Current Cancer Drug Targets Animal Models for the Evaluation of Theranostic Radiopharmaceuticals
Current Radiopharmaceuticals Designing Prodrugs Based on Special Residues of Human Serum Albumin
Current Topics in Medicinal Chemistry The Involvement of Heat Shock Proteins and Related Molecules in the Resistance to Therapies in Breast and Gynecologic Cancer
Current Cancer Therapy Reviews Recent Advances and Approaches in Targeting Apoptosis Signaling Pathways for Anti-Cancer Therapeutics
Current Cancer Therapy Reviews Anti-Angiogenic Drugs and Biomarkers in Non-Small-Cell Lung Cancer: 'A Hard Days Night'
Current Pharmaceutical Design Induction of Tumour Cell Senescence: A New Strategy in Anticancer Treatment
Medicinal Chemistry Reviews - Online (Discontinued) EGFR Transactivation by Peptide G Protein-Coupled Receptors in Cancer
Current Drug Targets Antioxidant Supplementation on Cancer Risk and During Cancer Therapy: An Update
Current Topics in Medicinal Chemistry Induced pluripotent stem cell-derived mesenchymal stem cells: A leap toward personalized therapies.
Current Stem Cell Research & Therapy Breaking the Barrier of Cancer Through Liposome Loaded with Phytochemicals
Current Drug Delivery Enediyne Anticancer Antibiotic Lidamycin: Chemistry, Biology and Pharmacology
Anti-Cancer Agents in Medicinal Chemistry The Roles of Chromatin Remodeling Proteins in Cancer
Current Protein & Peptide Science The Role of the Healthy Dietary Intake in Women with Human Papilloma Virus
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)